By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


American Society of Clinical Oncology 

225 Reinekers Lane
Suite 650
Alexandria  Virginia  22314  U.S.A.
Phone: 703-299-0150 Fax: 703-299-1044


Company News
Celgene (CELG) Release: Data Presented At ASCO GI Highlight The Feasibility Of Second-Line Treatment In Patients With Metastatic Pancreatic Cancer Who Have Received First-Line Abraxane Plus Gemcitabine 1/25/2016 11:29:51 AM
Boston Biomedical's Investigational Cancer Stem Cell Pathway Inhibitor, Napabucasin (BBI608), Featured At The ASCO 2016 Gastrointestinal Cancers Symposium 1/25/2016 6:20:58 AM
XBiotech To Attend And Present At The ASCO 2016 Gastrointestinal Cancers Symposium 1/21/2016 11:26:24 AM
BTG plc (BTG.L) Announces Presentation of New Vistogard (uridine triacetate) Data At ASCO Gastrointestinal Cancers Symposium (ASCO-GI) 1/20/2016 8:14:22 AM
NewLink Genetics (NLNK) To Present Phase 1b Data On Indoximod In Combination Therapy In Patients With Metastatic Pancreatic Cancer At ASCO GI 1/20/2016 8:03:32 AM
Bayer (BAY) To Highlight Latest Stivarga (regorafenib) Tablets Research At ASCO GI 2016 1/20/2016 6:27:03 AM
Tokai Pharmaceuticals (TKAI) Announces Presentation Of New Data Highlighting Unique Galeterone Mechanism At ASCO Genitourinary Cancers Symposium 1/11/2016 12:30:39 PM
Merrimack (MACK) To Present Updated Overall Survival Analysis Of Phase 3 NAPOLI-1 Study Of ONIVYDE (irinotecan liposome injection) At The ASCO 2016 Gastrointestinal Cancers Symposium 1/11/2016 6:26:36 AM
Myriad Genetics (MYGN) Advances Prostate And Renal Cancer Molecular Diagnostic Tests At The 2016 ASCO Genitourinary Cancers Symposium 1/7/2016 10:23:09 AM
Exelixis (EXEL) Announces Positive Results From Subgroup Analyses Of The METEOR Phase 3 Pivotal Trial Of Cabozantinib In Advanced Renal Cell Carcinoma To Be Presented At ASCO 2016 Genitourinary Cancerssymposium 1/5/2016 10:00:36 AM